Skip to main content
English
中文
Log In
Log in
Log in with ORCID
NTU Single Sign On
Have you forgotten your password?
Home
College of Medicine / 醫學院
Oncology / 腫瘤醫學研究所
EXPLORING THE ANTI-TUMOR EFFICACY OF COMBINATION THERAPY WITH INHIBITORS TARGETING THE INSULIN-LIKE GROWTH FACTOR (IGF) AND PI3K/AKT/MTOR SIGNALING PATHWAYS FOR HEPATOCELLULAR CARCINOMA (HCC)
Details
EXPLORING THE ANTI-TUMOR EFFICACY OF COMBINATION THERAPY WITH INHIBITORS TARGETING THE INSULIN-LIKE GROWTH FACTOR (IGF) AND PI3K/AKT/MTOR SIGNALING PATHWAYS FOR HEPATOCELLULAR CARCINOMA (HCC)
Resource
Ann. Oncol., 23, 16-16
Journal
Ann. Oncol.
Journal Issue
23
Pages
16-16
Date Issued
2012
Date
2012
Author(s)
Ou, D. -L.
Hsu, C.
Lee, B. -S.
Chang, Y. -C.
Cheng, Y. -C.
Cheng, A. -L.
URI
http://ntur.lib.ntu.edu.tw//handle/246246/259097
File(s)
Loading...
Loading...
Download
Name
index.html
Size
23.1 KB
Format
HTML
Checksum
(MD5):382bbd7e7cfac3387ebe7dc404c0f0bb
